Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beta blockers and glucose metabolism in chronic heart failure: friend or foe?

Literature DB >> 18026703

Beta blockers and glucose metabolism in chronic heart failure: friend or foe?

W Doehner, S D Anker.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 18026703 DOI： 10.1007/s00392-008-0609-1

Source DB: PubMed Journal: Clin Res Cardiol ISSN： 1861-0684 Impact factor: 5.460

× No keyword cloud information.

31 in total

Review 1. Cardiovascular protection using beta-blockers: a critical review of the evidence.

Authors: Sripal Bangalore; Franz H Messerli; John B Kostis; Carl J Pepine
Journal: J Am Coll Cardiol Date: 2007-07-30 Impact factor: 24.094

2. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Authors: Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Journal: Lancet Date: 2003-03-29 Impact factor: 79.321

3. After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.

Authors: Okcan Basat; Sema Ucak; Selcuk Seber; Erkan Oztekin; Yuksel Altuntas
Journal: Clin Res Cardiol Date: 2006-02-06 Impact factor: 5.460

Review 4. Gender differences in the metabolic syndrome and their role for cardiovascular disease.

Authors: V Regitz-Zagrosek; E Lehmkuhl; M O Weickert
Journal: Clin Res Cardiol Date: 2006-01-30 Impact factor: 5.460

Review 5. Prognosis and therapy approaches of cardiac cachexia.

Authors: Jochen Springer; Gerasimos Filippatos; Yoshihiro J Akashi; Stefan D Anker
Journal: Curr Opin Cardiol Date: 2006-05 Impact factor: 2.161

6. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.

Authors: Wolfram Doehner; Alexander C Bunck; Mathias Rauchhaus; Stephan von Haehling; Frank M Brunkhorst; Mariantonietta Cicoira; Carsten Tschope; Piotr Ponikowski; Ralf A Claus; Stefan D Anker
Journal: Eur Heart J Date: 2007-03-12 Impact factor: 29.983

7. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors: Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal: Eur Heart J Date: 2005-01-09 Impact factor: 29.983

8. Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure.

Authors: J W Swan; C Walton; I F Godsland
Journal: Clin Sci (Lond) Date: 1994-03 Impact factor: 6.124

Review 9. The role of heart rate in the development of cardiovascular disease.

Authors: J-C Reil; M Böhm
Journal: Clin Res Cardiol Date: 2007-06-27 Impact factor: 5.460

10. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.

Authors: Matej Podbregar; Gorazd Voga
Journal: J Card Fail Date: 2002-12 Impact factor: 5.712

4 in total

4. Mandatory oral glucose tolerance tests identify more diabetics in stable patients with chronic heart failure: a prospective observational study.

Authors: Bert O Eijnde; Paul Dendale; An Lm Stevens; Dominique Hansen; Vincent Vandoren; Rob Westerlaken; An Creemers
Journal: Diabetol Metab Syndr Date: 2014-03-27 Impact factor: 3.320